Kiniksa Pharmaceuticals International Plc (KNSA) Growth Rates Comparisons to Major Pharmaceutical Preparations Industry, Sector, Market. Sales, Income, EPS
CSIMarket Company Name, Ticker, Industry, else..
 
Kiniksa Pharmaceuticals International Plc  (NASDAQ: KNSA)
 

Kiniksa Pharmaceuticals International Plc Growth Comparisons

Select each growth Category to receive further Information




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

KNSA Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q1 MRQ) 55.51 % 12.24 % 9.19 % 10.9 %
Q / Q Revenue Growth (Q1 MRQ) 6.01 % -2.93 % -3.28 % 8.32 %
Y / Y Revenue Growth (for 12 months ending Q1 TTM) 56.71 % 9.25 % 7.98 % %
Sequential Revenue Growth (for 12 months ending Q1 TTM) 11.29 % 2.69 % 2.03 % 2.61 %
Revenue 5 Year Average Growth - 7.41 % 8.65 % 10.59 %


KNSA's Growth Comparisons in I. Quarter 2026




Strong but slowing Revenue rise by Kiniksa Pharmaceuticals International Plc of 55.51% year on year , in the first quarter 2026 to 214 millions, was higher than the 12.24% rise in the Major Pharmaceutical Preparations industry, and 9.19% growth in the Healthcare sector. Comparing the first quarter sales growth, both Major Pharmaceutical Preparations industry and Kiniksa Pharmaceuticals International Plc outperformed 10.9% overall market increase.

Comparing the company's Revenue to the fourth quarter results, sales were higher by 6.01% . On the yearly basis, average annual sales growth for Kiniksa Pharmaceuticals International Plc is %, while S & P 500's including only Businesses with the first quarter 2026 earnings, average annual sales growth is 10.59% over the past five years.

KNSA Growth Rates by Company's Segments

Segment Name
Y / Y
Sequential
Product revenue net
55.51 %
-
Accounts receivable
-
-
Other current liabilities
-5.15 %
-
Pharmaceutical
55.51 %
-
Pharmaceutical United States
55.58 %
-
Total
55.51 %
-68.38 %
Product
-
-
Pharmaceutical Segment
-
-
US
-
-
GB
-
-


Growth Rates of KNSA's Income in the first quarter 2026


KNSA Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q1 MRQ) 120.52 % -8.69 % 5.13 % 97.6 %
Sequential Operating Income Change (Q1 MRQ) 48.05 % -4.52 % 0.89 % 48.13 %
Y / Y Operating Income Growth (Q1 TTM) - 30.63 % 30.7 % 40.67 %
Sequential Operating Income Growth (Q1 TTM) 20.71 % -2.27 % 4.82 % 20.86 %
Operating Income 5 Year Avg. Change - 14.39 % 10.39 % 18.76 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q1 MRQ) 164.57 % -34.78 % -25.81 % 90.69 %
Sequential Income from Cont. Ops. Change (Q1 MRQ) 59.11 % -2.61 % -66.16 % 27.07 %
Y / Y Income from Cont. Ops. Change (Q1 TTM) - 6.3 % 2.68 % 57.33 %
Sequential Income from Cont. Ops. Change (Q1 TTM) 23.82 % -10.02 % -5.02 % 18.65 %
Income from Cont. Ops. 5 Year Avg. Change - -0.55 % 0.17 % -28.52 %

KNSA Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q1 MRQ) 164.57 % -35.13 % -26.29 % 90.69 %
Q / Q Net Income Growth (Q1 MRQ) 59.11 % 2.8 % -0.86 % 27.07 %
Y / Y Net Income Change (Q1 TTM) - 5.21 % 15.47 % 57.33 %
Sequential Net Income Change (Q1 TTM) 23.82 % -10.17 % -6.74 % 18.65 %
Net Income 5 Year Avg. Growth - 14.55 % 9.21 % 22.96 %

KNSA's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q1 MRQ) 150 % -40.16 % -25.81 % 90.69 %
Sequential EPS from Cont. Ops. Change (Q1 MRQ) 60.58 % -7.73 % -66.16 % 27.07 %
Y / Y EPS from Cont. Ops. Change (Q1 TTM) - - - -
Sequential EPS from Cont. Ops. Change (Q1 TTM) 22.59 % - - 4.88 %
EPS from Cont. Ops. 5 Year Avg. Growth - -10.79 % 0.17 % -28.52 %



KNSA EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q1 MRQ) 145.45 % -40.49 % -26.29 % -28.52 %
Q / Q EPS Net Growth (Q1 MRQ) 50 % -2.61 % -0.86 % 27.07 %
Y / Y EPS Net Change (for 12 months ending Q1 TTM) - - - 7.62 %
Sequential EPS Net Change (for 12 months ending Q1 TTM) 21.33 % - 0.15 % 4.93 %
EPS Net 5 Year Avg. Change - 14.55 % 9.21 % 22.96 %



Despite the -40.49% decline in Major Pharmaceutical Preparations industry, Kiniksa Pharmaceuticals International Plc showed impressive surge in EPS in the first quarter by 145.45% from the same quarter a year ago, to $0.27, Healthcare sector dropped -26.29%. Despite modest earnings per share in the Major Pharmaceutical Preparations industry and ind the Healthcare sector, Kiniksa Pharmaceuticals International Plc reported above average market earnings per share growth.

The bottom-line grew by 50% from the fourth quarter. Average yearly income per share growth for Kiniksa Pharmaceuticals International Plc is %, while S & P 500's average annual income per share increase is 22.96% over the five years, including only Businesses with the first quarter 2026 earnings reports.

KNSA Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q1 MRQ) 125.14 % 25.53 % 48.48 % 48.62 %
Sequential Free Cash Flow Change (Q1 MRQ) -6.05 % -42.35 % -46.96 % 34.18 %
Y / Y Free Cash Flow Change (Q1 TTM) 275.52 % 11.91 % 18.61 % 60.27 %
Sequential Free Cash Flow Change (Q1 TTM) 20.39 % 3.24 % 5.39 % 15.75 %
Free Cash Flow 5 Year Avg. Change - 1.86 % 0.92 % 8.28 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q1 MRQ) - - - 339.02 %
Sequential Net Cash Flow Change (Q1 MRQ) - - - 216.68 %
Y / Y Net Cash Flow Change (Q1 TTM) 104.44 % - - 209.43 %
Sequential Net Cash Flow Change (Q1 TTM) - - - 152.64 %
Net Cash Flow 5 Year Avg. Change - 29.88 % 6.46 % 1.06 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q1 MRQ) 62.63 % 11.25 % 8.23 % 120.03 %
Sequential Capital Expenditures Change (Q1 MRQ) -74.57 % -25.6 % -22.09 % 36.87 %
Y / Y Capital Expenditures Change (Q1 TTM) 458.22 % 16.65 % 7.86 % 109.38 %
Sequential Capital Expenditures Change (Q1 TTM) 3.95 % 2.92 % 1.6 % 23.05 %
Capital Expenditures 5 Year Avg. Change 40.84 % 7.84 % 8.61 % 14.73 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Y/Y Annual




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.